These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32303164)

  • 1. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention.
    Siasos G; Skotsimara G; Oikonomou E; Sagris M; Vasiliki-Chara M; Bletsa E; Stampouloglou P; Theofilis P; Charalampous G; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2780-2788. PubMed ID: 32303164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy in diabetes: which, when, and for how long?
    Ajjan RA; Kietsiriroje N; Badimon L; Vilahur G; Gorog DA; Angiolillo DJ; Russell DA; Rocca B; Storey RF
    Eur Heart J; 2021 Jun; 42(23):2235-2259. PubMed ID: 33764414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.
    Colwell JA
    Am J Cardiovasc Drugs; 2004; 4(2):87-106. PubMed ID: 15049721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of and Recent Evidence for Antiplatelet Therapy in Prevention of Cardiovascular Disease in Diabetes.
    Sharma AN; Deyell JS; Sharma SN; Barseghian A
    Curr Cardiol Rep; 2019 Jun; 21(8):78. PubMed ID: 31254105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation.
    Rivera-Caravaca JM; Camelo-Castillo A; Ramírez-Macías I; Gil-Pérez P; López-García C; Esteve-Pastor MA; Orenes-Piñero E; Tello-Montoliu A; Marín F
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
    Nicolas J; Razuk V; Giustino G; Mehran R
    Future Cardiol; 2021 May; 17(3):521-534. PubMed ID: 33728965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
    J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Prevention with Antithrombotic Therapies in Stable Ischemic Heart Disease Patients: a Review.
    Shanker A; Bhupathi V
    Curr Cardiol Rep; 2019 May; 21(7):56. PubMed ID: 31104152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease.
    Park Y; Franchi F; Rollini F; Angiolillo DJ
    Circ J; 2016; 80(4):791-801. PubMed ID: 26984587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease.
    Welsh RC; Peterson ED; De Caterina R; Bode C; Gersh B; Eikelboom JW
    Am Heart J; 2019 Dec; 218():100-109. PubMed ID: 31715433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.
    Königsbrügge O; Schmaldienst S; Auinger M; Klauser-Braun R; Lorenz M; Tabernig S; Kletzmayr J; Enzenberger B; Eigner M; Hecking M; Siller-Matula JM; Pabinger I; Säemann M; Ay C
    Atherosclerosis; 2020 Apr; 298():1-6. PubMed ID: 32126388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.